Liftstream is an executive search recruitment company in the life sciences sector
Kiadis rides high after positive clinical data
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged 4SC, acute lymphoblastic leukaemia, Acute Myeloid Leukaemia, ALL, Alta Partners, AML, Amsterdam Biotech, ATIR, Cardion, clinical data, Dr Manfred Rudiger, Dutch, Esprit Capital, haematology, holland, Igenon, Kiadis, Life Science Partners, MDS, MedSciences Capital, myelodysplastic syndome, oncology, Orphan Drug, phase II study, t2cure
Leave a comment
Merus Biopharmaceuticals building to future with strong pipeline
Authored by James Sheppard
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged Acute Myeloid Leukaemia, Affitech, Aglaia Biomedical Ventures, Amsterdam Biotech, Astellas, Bay City Capital, bispecific, Charity, Crucell, Dr Setareh van Driel Shamsili, European Society of Hematology, funding, government, hematology, IND, Johnson & Johnson, Life Science Partners, London Biotech, London Innovation Centre, MCLA-117, Merus Biopharmaceuticals, Mr Jason Avery, Netherlands, Novartis Venture Fund, oncology, Pfizer, Series B funding, Ton Logtenberg
Leave a comment